[Congressional Record Volume 170, Number 124 (Tuesday, July 30, 2024)]
[Senate]
[Pages S5587-S5588]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                         SUBMITTED RESOLUTIONS

                                 ______
                                 

 SENATE RESOLUTION 775--EXPRESSING SUPPORT FOR THE DESIGNATION OF JULY 
         15, 2024, AS ``NATIONAL LEIOMYOSARCOMA AWARENESS DAY''

  Ms. STABENOW submitted the following resolution; which was referred 
to the Committee on Health, Education, Labor, and Pensions:

                              S. Res. 775

       Whereas leiomyosarcoma is a malignant sarcoma subtype, 1 of 
     70 to 100 such subtypes, that arises in smooth muscle and has 
     several subtypes itself due to its vascularity and bone 
     invasion;
       Whereas leiomyosarcoma is designated by the National 
     Institutes of Health as a rare form of cancer;

[[Page S5588]]

       Whereas leiomyosarcoma is largely resistant to standard 
     chemotherapy treatments, radiation treatments, and 
     immunotherapy trials, with 40-year-old chemotherapy 
     treatments still in use;
       Whereas leiomyosarcoma affects all age groups, including 
     children, young adults, the middle-aged, and the elderly, and 
     all genders;
       Whereas leiomyosarcoma is diagnosed in more than 2,000 
     individuals in the United States each year;
       Whereas, with respect to leiomyosarcoma, research and 
     clinical trials remain complicated and extremely costly due 
     to the difficulty of recruiting patients;
       Whereas survival and longevity for individuals with 
     leiomyosarcoma has not significantly improved for at least 30 
     years;
       Whereas multidisciplinary care coordination teams, because 
     of their expertise and experience, are critical to the health 
     of leiomyosarcoma patients;
       Whereas researchers continue to strive to improve quality 
     of life for leiomyosarcoma patients, improve outcomes in 
     clinical trials, and promote enhanced survivorship; and
       Whereas increased education and awareness about sarcoma and 
     leiomyosarcoma will contribute to the well-being of the 
     communities of the United States: Now, therefore, be it
       Resolved, That the Senate--
       (1) supports the designation of July 15, 2024, as 
     ``National Leiomyosarcoma Awareness Day'';
       (2) recognizes the challenges faced by leiomyosarcoma 
     patients; and
       (3) commends the dedication of organizations, volunteers, 
     researchers, and caregivers across the United States working 
     to improve the quality of life of leiomyosarcoma patients and 
     their families.

                          ____________________